• Published On: October 1, 2026

    Is 26.6% efficacy worth a 75.7% side-effect rate? Three authors re-ran the FDA's own mFLUSIVA data and found two unexplained deaths per hospitalization averted.

  • Published On: March 13, 2025

    Are public health agencies prioritizing science—or fear? From flu treatment guidelines to fear-driven vaccine campaigns, the public has been fed conflicting messages for years. But what’s really behind these decisions? This week Dr. Robert Malone joins IMA Senior Fellow Dr. Ryan Cole to discuss how public health narratives shape virus treatments and vaccine policies. Don’t miss this crucial discussion with two of the most outspoken experts in medicine.

  • Published On: November 16, 2022

    Dr. Paul Marik and Dr. Pierre Kory join Betsy Ashton to talk about the rise in Flu, RSV and COVID-19, and how you can prepare your family for them.